Pharmacological advances in anti‐retroviral therapy for human immunodeficiency virus‐1 infection: A comprehensive review
Reviews in Medical Virology · 2024
DOI: 10.1002/rmv.2529 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2024. Verfasst von Nursyuhada Azzman und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, HIV-1. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Higher Education, Malaysia, Monash University Malaysia.
Abstract (Originalsprache)
The discovery of anti‐retroviral (ARV) drugs over the past 36 years has introduced various classes, including nucleoside/nucleotide reverse transcriptase inhibitors, non‐nucleoside reverse transcriptase inhibitors, protease inhibitor, fusion, and integrase strand transfer inhibitors inhibitors. The introduction of combined highly active anti‐retroviral therapies in 1996 was later proven to combat further ARV drug resistance along with enhancing human immunodeficiency virus (HIV) suppression. As though the development of ARV therapies was continuously expanding, the variation of action caused by ARV drugs, along with its current updates, was not comprehensively discussed, particularly for HIV‐1 infection. Thus, a range of HIV‐1 ARV medications is covered in this review, including new developments in ARV therapy based on the drug's mechanism of action, the challenges related to HIV‐1, and the need for combination therapy. Optimistically, this article will consolidate the overall updates of HIV‐1 ARV treatments and conclude the significance of HIV‐1‐related pharmacotherapy research to combat the global threat of HIV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
- Faculty of Pharmacy, Universiti Teknologi MARA, Cawangan Pulau Pinang Kampus Bertam, Permatang Pauh, Pulau Pinang, Malaysia.
- Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan.
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
- Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
- Nutrition Unit, Nutrition, Metabolism and Cardiovascular Research Centre (NMCRC), Level 3, Block C, Institute for Medical Research (IMR), National Institutes of Health (NIH) Complex, Ministry of Health Malaysia (MOH), S…
ORCID-Profile: Nursyuhada Azzman
Förderung
- Ministry of Higher Education, Malaysia
- Monash University Malaysia
Zitieren
APA
Azzman, N., Gill, M. S. A., Hassan, S. S., Christ, F., Debyser, Z., Mohamed, W. A. S., & Ahemad, N. (2024). Pharmacological advances in anti‐retroviral therapy for human immunodeficiency virus‐1 infection: A comprehensive review. Reviews in Medical Virology. https://doi.org/10.1002/rmv.2529
Vancouver
Azzman N, Gill MSA, Hassan SS, Christ F, Debyser Z, Mohamed WAS, et al. Pharmacological advances in anti‐retroviral therapy for human immunodeficiency virus‐1 infection: A comprehensive review. Reviews in Medical Virology. 2024. doi:10.1002/rmv.2529
BibTeX
@article{Azzman2024,
author = {Azzman, Nursyuhada and Gill, Muhammad Shoaib Ali and Hassan, Sharifah Syed and Christ, Frauke and Debyser, Zeger and Mohamed, Wan Ahmad Syazani and Ahemad, Nafees},
title = {Pharmacological advances in anti‐retroviral therapy for human immunodeficiency virus‐1 infection: A comprehensive review},
journal = {Reviews in Medical Virology},
year = {2024},
doi = {10.1002/rmv.2529}
}
EUVIMED